Aurobindo Pharma wrests second position among drug firms from Lupin

While Lupin recorded a 10.6 per cent decline in its sales for the period, the largest, Sun Pharma, recorded a 17.4 per cent fall

P V Ramaprasad Reddy, co-founder of Aurbindo Pharma, is known for his ability to learn along the way. Some years ago he moved to the US to build business in new segments such as injectables, controlled substance and nutraceuticals. This has now helped the firm move up the value chain in formulations business to claim the second spot among Indian pharma companies.

With sales of over Rs 122.4 billion in nine months of the current financial year, it is ahead of Rs 115.8 billion recorded by Lupin but behind Sun Pharma, which reported Rs 193.5 billion sales.

This is a 8.7 per